US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

689.59

-11.4736-1.64%

Number of Gainers:45

Number of Losers:100

Number of Flat:9

PE:- -

High:703.50

Open:700.87

Low:686.25

Close:701.07

Volume:325.61M

Turnover:9.76B

Market Cap:481.91B

Float Cap:365.77B

Loading ...

Global-E COO Tamari Shahar Sells 24,999 Shares for $1.04 Million

Cytek Biosciences Shares Drop After Jury Says it Owes $56 Million in Damages

Agilon Health Price Target Raised to $85.00/Share from $31.00 by JP Morgan

Erasca Wins FDA Fast Track for Pancreatic Therapy

Aveanna price target raised to $15 from $11 at Truist

Zhihu Inc Expected to Post a Loss of 7 Fen a Share - Earnings Preview

CVRx Shareholder Chernett Urges Board to Start Immediate Sale Process to Strategic Buyer

Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer

THOMSON REUTERS

Jorey Chernett: Calls on CVRx Board Initiate a Comprehensive Review of Strategic Alternatives

THOMSON REUTERS

CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy

THOMSON REUTERS

Erasca Says FDA Grants Fast-Track Status to ERAS-0015 for Metastatic Pancreatic Cancer

Edgewise Says Phase 2 Cirrus-HCM Trial Shows Positive Top-Line Data for EDG-7500 in Hypertrophic Cardiomyopathy

Erasca, - Plans Three Potentially Registration-Enabling Trials for Eras-0015 in Pancreatic and Lung Cancers

THOMSON REUTERS

Erasca, - Additional Phase 1 Data for Eras-0015 Expected in H1 2027

THOMSON REUTERS

Erasca Granted FDA Fast Track Designation for Pan-Ras Molecular Glue Eras-0015 in Patients with Metastatic Pancreatic Adenocarcinoma

THOMSON REUTERS

BioXcel Therapeutics Amends Credit Agreement, Extends Financing Deadline

Analysts Offer Insights on Healthcare Companies: Enovis (ENOV) and Aveanna Healthcare Holdings (AVAH)

How Deeper Shopify AXON Integration At AppLovin (APP) Has Changed Its Investment Story

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL)

Alkami price target raised to $25 from $22 at Needham

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK4539/news?page=26"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":689.5945,"timestamp":1788292799999,"preClose":701.0681,"halted":0,"volume":325607950,"delay":0,"changeRate":-0.016366,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-11.473633,"latestTime":"09-01 16:00:00 EDT","open":700.8716,"high":703.5049,"low":686.25476,"amount":9755081900.67638,"amplitude":0.024605,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.432153,"peRate":146.268293,"turnoverRate":0.025137,"increases":45,"decrements":100,"flats":6,"marketCap":481907544284.625,"floatMarketCap":365773227048.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":703.5049,"amplitude":0.024605,"preClose":701.0681,"low":686.25476,"pbRate":"5.432153","latestPrice":689.5945,"volume":325607950,"delay":0,"open":700.8716,"prevYearClose":881.5255,"prevWeekClose":700.4571,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":710.5842,"twentyDayClose":709.8907,"sixtyDayClose":711.562,"secType":"PLATE","market":"US","turnoverRate":0.025137,"peRate":146.268293,"marketCap":481907544284.625,"floatMarketCap":365773227048.75,"timestamp":1788292799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":45,"down":100,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:26,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661162272","title":"Global-E COO Tamari Shahar Sells 24,999 Shares for $1.04 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661162272","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661162272?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:43","pubTimestamp":1787582621,"startTime":"0","endTime":"0","summary":"Global-e COO Tamari Shahar sells 24,999 shares for $1.04 millionGlobal-e Online COO and director Tamari Shahar sold 24,999 ordinary shares on Aug. 19 at USD 41.63.Direct holdings fell to 3,856,689 ord","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL1t1mV7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Global-E COO Tamari Shahar Sells 24,999 Shares for $1.04 Million","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4122","BK4539","BK4220","GLBE","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661742342","title":"Cytek Biosciences Shares Drop After Jury Says it Owes $56 Million in Damages","url":"https://stock-news.laohu8.com/highlight/detail?id=2661742342","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661742342?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:09","pubTimestamp":1787580540,"startTime":"0","endTime":"0","summary":"Shares of Cytek Biosciences fell after the company said it would challenge a jury's decision to make it pay $56 million in damages in a patent infringement case.The stock was down 7.2% at $4.47 Monday. Shares are now down 12% since the start of the year.The company said Friday that in a patent infringement lawsuit brought by Beckman Coulter, a jury found in Cytek's favor on three of four claims. On the remaining claim, the jury found no literal infringement, but did find infringement under the doctrine of equivalents.The jury awarded past damages consisting of $20 million in lost profit and $36.1 million in royalties. Cytek said it would pursue post-verdict motions challenging the jury's infringement finding and the related damages.Beckman Coulter had alleged that Cytek's Aurora flow cytometers violated Beckman's patent rights for technology used in its CytoFLEX platform.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","IE000M9KFDE8.USD","LU1917777945.USD","SG9999001176.SGD","IE0004445239.USD","LU1551013342.USD","LU1923622614.USD","BK4533","LU0390134368.USD","LU1023059063.AUD","LU1057294990.SGD","DHR","SG9999001176.USD","BK4581","LU0820562030.AUD","IE00BQXX3D17.EUR","LU0187121727.USD","LU1791710582.SGD","LU2125909593.SGD","LU0097036916.USD","LU0320765059.SGD","SGXZ57979304.SGD","LU0289739343.SGD","BK4504","LU2106854487.HKD","LU2211814178.USD","LU0432979614.USD","LU2355687059.USD","SG9999013999.USD","LU0289961442.SGD","LU0689472784.USD","LU1791710400.SGD","LU1804176565.USD","BK4534","LU2244417387.USD","FMED","LU0289960550.SGD","BK4588","BK4539","LU1551013425.SGD","LU2125910179.SGD","SGXZ23171101.USD","LU1267930730.SGD","LU0109391861.USD","CTKB","LU1923621640.USD","LU2112291526.USD","LU0157215616.USD","LU0820561818.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661274143","title":"Agilon Health Price Target Raised to $85.00/Share from $31.00 by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661274143","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661274143?lang=en_us&edition=fundamental","pubTime":"2026-08-24 22:07","pubTimestamp":1787580420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGL/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGL","BK4196","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661727976","title":"Erasca Wins FDA Fast Track for Pancreatic Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661727976","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661727976?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:48","pubTimestamp":1787575690,"startTime":"0","endTime":"0","summary":"Erasca ( ($ERAS) ) has shared an announcement. On August 24, 2026, Erasca, Inc. reported that the U.S. Food and Drug Administration granted Fast Tr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/erasca-wins-fda-fast-track-for-pancreatic-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/erasca-wins-fda-fast-track-for-pancreatic-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ERAS","BK4539","BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661796152","title":"Aveanna price target raised to $15 from $11 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2661796152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661796152?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:37","pubTimestamp":1787575061,"startTime":"0","endTime":"0","summary":"Truist raised the firm’s price target on Aveanna (AVAH) to $15 from $11 and keeps a Hold rating on the shares. The firm is updating its estimates t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aveanna-price-target-raised-to-15-from-11-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aveanna-price-target-raised-to-15-from-11-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4539","AVAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276012","title":"Zhihu Inc Expected to Post a Loss of 7 Fen a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276012","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276012?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:32","pubTimestamp":1787574736,"startTime":"0","endTime":"0","summary":"Zhihu Inc <ZH.N> expected to post a loss of7fen a share - Earnings PreviewZhihu IncZH.N,ZHis expected to  show a fall in quarterly revenue when it reports  results on August 26 for the period ending June 30 2026The Beijing-based  company is expected to report a 1.0% decrease in revenue to CNY709.517 million from CNY716.89 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.LSEG's mean analyst estimate for Zhihu Inc is for a loss of 7 fen per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"The average consensus recommendation for the online services peer group is also \"Buy\".Wall Street's median 12-month price target for Zhihu Inc is $4.20, about 30.4% above its last closing price of $3.22This summary was machine generated August 24 at 12:32 GMT.  All figures in Chinese yuan renminbi unless otherwise stated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL8N44L0VH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZH","HK0000500386.USD","HK0000252160.HKD","BK4509","02390","BK4539","BK4077","BK1095","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276025","title":"CVRx Shareholder Chernett Urges Board to Start Immediate Sale Process to Strategic Buyer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276025","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276025?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:32","pubTimestamp":1787574727,"startTime":"0","endTime":"0","summary":"CVRx shareholder Chernett urges board to start immediate sale process to strategic buyerPointillist Family Office founder Jorey Chernett, holding more than 5.5% of CVRx shares, urged the board to star","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL85xzBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4539","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661727679","title":"Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661727679","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661727679?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574615,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L06M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CVRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276037","title":"Jorey Chernett: Calls on CVRx Board Initiate a Comprehensive Review of Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276037","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276037?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574615,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L06M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276799","title":"CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276799?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA9ZG5KY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276304","title":"Erasca Says FDA Grants Fast-Track Status to ERAS-0015 for Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276304","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276304?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:03","pubTimestamp":1787572997,"startTime":"0","endTime":"0","summary":"Erasca says FDA grants fast-track status to ERAS-0015 for metastatic pancreatic cancerErasca secured FDA Fast Track status for ERAS-0015 to treat metastatic pancreatic adenocarcinoma, accelerating its","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL14y9vR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","IE00BKPKM429.USD","SG9999014039.USD","LU2095319765.USD","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","SG9999014005.SGD","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","BK4539","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","LU0314104364.USD","BK4585","LU2210150020.SGD","SG9999014021.USD","SG9999014013.SGD","IE00BQXX3F31.USD","ERAS","NDAQ","BCDF","IE00BN0W2T93.GBP","BK4112","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276378","title":"Edgewise Says Phase 2 Cirrus-HCM Trial Shows Positive Top-Line Data for EDG-7500 in Hypertrophic Cardiomyopathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276378","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276378?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:02","pubTimestamp":1787572938,"startTime":"0","endTime":"0","summary":"Edgewise says Phase 2 CIRRUS-HCM trial shows positive top-line data for EDG-7500 in hypertrophic cardiomyopathyEdgewise Therapeutics flagged positive top-line results from its 12-week Phase 2 CIRRUS-H","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL5MQ07j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661827633","title":"Erasca, - Plans Three Potentially Registration-Enabling Trials for Eras-0015 in Pancreatic and Lung Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661827633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661827633?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA40QQ31:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ERAS","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661763892","title":"Erasca, - Additional Phase 1 Data for Eras-0015 Expected in H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661763892","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661763892?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA40QQ31:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276849","title":"Erasca Granted FDA Fast Track Designation for Pan-Ras Molecular Glue Eras-0015 in Patients with Metastatic Pancreatic Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276849?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA40QQ31:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","ERAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276563","title":"BioXcel Therapeutics Amends Credit Agreement, Extends Financing Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276563?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:49","pubTimestamp":1787572174,"startTime":"0","endTime":"0","summary":"Bioxcel Therapeutics ( ($BTAI) ) has shared an announcement. On August 21, 2026, BioXcel Therapeutics entered into a Thirteenth Amendment to its ex...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioxcel-therapeutics-amends-credit-agreement-extends-financing-deadline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioxcel-therapeutics-amends-credit-agreement-extends-financing-deadline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275904","title":"Analysts Offer Insights on Healthcare Companies: Enovis (ENOV) and Aveanna Healthcare Holdings (AVAH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275904","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275904?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:40","pubTimestamp":1787571627,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Enovis (ENOV) and Aveanna Healthcare Holdings (AVA...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-enovis-enov-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-enovis-enov-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z6F94.USD","XBI","XLV","BK4082","ENOV","LABU","BK4539","LU2065732104.USD","BK4588","AVAH","BK4196","BK4581","IE0034390439.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661743342","title":"How Deeper Shopify AXON Integration At AppLovin (APP) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2661743342","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661743342?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:25","pubTimestamp":1787570741,"startTime":"0","endTime":"0","summary":"In recent days, AppLovin detailed a deeper integration of its AXON advertising platform within Shopify’s commerce ecosystem, aiming to use merchant and shopper data to improve how ads are targeted and measured across its network.\nThis closed-loop approach, combining Shopify commerce signals with AppLovin’s machine learning and owned ad supply, could meaningfully distinguish its offering from rivals in performance-focused digital advertising.\nNext, we’ll examine how this expanded Shopify-AXON...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/media/nasdaq-app/applovin/news/how-deeper-shopify-axon-integration-at-applovin-app-has-chan","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/media/nasdaq-app/applovin/news/how-deeper-shopify-axon-integration-at-applovin-app-has-chan","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2063271972.USD","LU0056508442.USD","LU1861215975.USD","LU2360106780.USD","LU2087625088.SGD","BK4588","IE00B894F039.SGD","BK4585","IE00B19Z9P08.USD","BK4539","IE00B19Z9Z06.USD","BK4608","CLOD","LU1852331112.SGD","LU0353189680.USD","LU2250418816.HKD","LU2360107168.USD","XDAT","APP","IE00BZ9MQY76.HKD","LU0097036916.USD","LU2290526834.HKD","BK4023","APPX","BK4009","LU0353189763.USD","LU0154236417.USD","BK4613","LU1861220033.SGD","APPC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661275889","title":"Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275889?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:20","pubTimestamp":1787570417,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Hea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eloxx-pharmaceuticals-elox-cingulate-inc-cing-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eloxx-pharmaceuticals-elox-cingulate-inc-cing-and-agilon-health-agl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4585","BK4588","BK4196","CING","BK4581","LU0128526141.USD","LU0029874061.USD","XBI","BK4137","LABU","AGL","ELOX","BK4007","XLV","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661027309","title":"Alkami price target raised to $25 from $22 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2661027309","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661027309?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:15","pubTimestamp":1787570144,"startTime":"0","endTime":"0","summary":"Needham raised the firm’s price target on Alkami (ALKT) to $25 from $22 and keeps a Buy rating on the shares after hosting meetings with its manage...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alkami-price-target-raised-to-25-from-22-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alkami-price-target-raised-to-25-from-22-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALKT","BK4023","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":41,"pageCount":26,"totalSize":817,"code":"91000000","status":"200"}]}}